In a letter to U.S. District Judge Sidney Stein in Manhattan,
prosecutors asked that the May 6 trial date be pushed back to
July or August, though they still oppose granting the Menendezes'
requests to be tried separately.
Prosecutors said the government "takes seriously the unexpected
medical development," and that an adjournment would let the
Democratic senator focus on his wife's health. They opposed
Nadine Menendez's request for an indefinite adjournment.
Lawyers for the senator and his wife did not immediately respond
to requests for comment.
Nadine Menendez has not disclosed her medical condition, but her
lawyers said it would require surgery within four to six weeks
and potentially significant follow-up treatment.
They also said that she would not be in a "physical or
psychological condition" to participate in the currently
scheduled trial, which is expected to last six weeks.
The couple and two other defendants have been charged in a
wide-ranging bribery conspiracy, and have pleaded not guilty.
Prosecutors accused the senator of accepting cash, gold bars and
a luxury car to wield his influence at home and on behalf of
Egypt's and Qatar's governments. They also charged the
Menendezes with obstruction of justice.
Senator Menendez was forced to give up his chairmanship of the
Senate Foreign Relations Committee following his arrest last
September, and has resisted many calls to resign.
He is up for re-election in November but chose not to run in New
Jersey's Democratic primary, and instead hopes to run as an
independent if he is exonerated.
Democrats and independents who caucus with them hold a 51-49
Senate majority. Several seats held by Democrats or independents
may be closely contested in November's election, and a seat in
West Virginia is widely expected to turn Republican.
(Reporting by Jonathan Stempel in New York; Editing by Peter
Graff)
[© 2024 Thomson Reuters. All rights
reserved.]
Copyright 2022 Reuters. All rights reserved. This material may
not be published, broadcast, rewritten or redistributed.
Thompson Reuters is solely responsible for this content.
|
|